Skip to Main Content

Author Details

Hisataka Kobayashi
Center for Cancer Research
1990
393
71
PMIDPaper TitleJournal TitlePublished Year
36223542Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.Mol Cancer Ther2023
37461129Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.Mol Cancer Ther2023
37254845Simultaneous multicolor imaging of lymph node chains using hydroporphyrin-doped near-infrared-emitting polymer dots.Nanomedicine (Lond)2023
37418480Correction: Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission.PLoS One2023
36966701The chemical basis of cytotoxicity of silicon-phthalocyanine-based near infrared photoimmunotherapy (NIR-PIT) and its implications for treatment monitoring.Curr Opin Chem Biol2023
36791566Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.Biomed Pharmacother2023
36169301Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-α expressing cells in vitro and in vivo.Cancer Sci2023
35003897CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.Oncoimmunology2022
35740662Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.Cancers (Basel)2022
35836056Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence Imaging.Methods Mol Biol2022
35398956Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment.Cancer Sci2022
35759343Comparison of the Effectiveness of IgG Antibody versus F(ab')<sub>2</sub> Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy.Mol Pharm2022
35696546Cyanine Phototruncation Enables Spatiotemporal Cell Labeling.J Am Chem Soc2022
35788695Antimicrobial strategy for targeted elimination of different microbes, including bacterial, fungal and viral pathogens.Commun Biol2022
35723065Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.Cancer Sci2022
35453596Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts.Biomedicines2022
35624180Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration.Cancer Immunol Immunother2022
35445836Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.Cancer Immunol Immunother2022
36465486Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.Oncoimmunology2022
36418422Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.Sci Rep2022
36176626Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect.Bioeng Transl Med2022
36169564Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy.Cancer Immunol Res2022
36297471Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin.Pharmaceutics2022
35892836Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice.Cancers (Basel)2022
36011036Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.Cancers (Basel)2022
36185287NIR-PIT: Will it become a standard cancer treatment?Front Oncol2022
35158887PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model.Cancers (Basel)2022
35013765Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.Cancer Immunol Immunother2022
32496557Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.Int Immunol2021
35403125Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green.Cancer Diagn Progn2021
36405499Near infrared photoimmunotherapy of cancer; possible clinical applications.Nanophotonics2021
33574087Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.Cancer Res2021
33543819Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green.Cancer Sci2021
33844539Norcyanine-Carbamates Are Versatile Near-Infrared Fluorogenic Probes.J Am Chem Soc2021
33502869Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.Mol Pharm2021
34518299Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.Mol Cancer Ther2021
34514846Future applications of and prospects for near-IR photoimmunotherapy: benefits and differences compared with photodynamic and photothermal therapy.Immunotherapy2021
34661083Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy.ACS Pharmacol Transl Sci2021
33996199Quantitative analysis of vascular changes during photoimmunotherapy using speckle variance optical coherence tomography (SV-OCT).Biomed Opt Express2021
34101947Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model.Cancer Sci2021
34064074Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy.Cancers (Basel)2021
33933782Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.EBioMedicine2021
34332294Near infrared photoimmunotherapy for cancers: A translational perspective.EBioMedicine2021
34134087Expanding the application of cancer near-infrared photoimmunotherapy.EBioMedicine2021
33997271Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity.Adv Ther (Weinh)2021
33462372Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.Sci Rep2021
31479610Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs).Bioconjug Chem2020
31871266Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity.Mol Cancer Ther2020
31953245Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.Cancer Immunol Res2020
33316807Near-Infrared Photoimmunotherapy for Cancers of the Gastrointestinal Tract.Digestion2020
  • 1 - 50 of 393

Recommended Authors

Dana-Farber Cancer Institute, Harvard University
Career Start Year 2015
Number of shared co-authors 0
Ottawa Hospital Research Institute
Career Start Year 2015
Number of shared co-authors 0
Career Start Year 2012
Number of shared co-authors 1
Southwest Hospital, Army Medical University
Career Start Year 2011
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2011
Number of shared co-authors 0
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 0
The Second Hospital of Dalian Medical University
Career Start Year 2010
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.
Career Start Year 2008
Number of shared co-authors 1
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Maastricht University
Career Start Year 2004
Number of shared co-authors 0
The University of Texas M.D. Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
The Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Guizhou University of Traditional Chinese Medicine
Career Start Year 2004
Number of shared co-authors 0
Maastricht University
Career Start Year 2003
Number of shared co-authors 0
University Health Network
Career Start Year 2001
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 1
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 7
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year 1990
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 2
Columbia University Medical Center Kreitchman PET Center
Career Start Year 1981
Number of shared co-authors 1
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 0
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 1

Collaborators

National Cancer Institute, National Institutes of Health
Co-authored papers 227
National Institutes of Health
Co-authored papers 46
University of Fukui.
Co-authored papers 35
Center for Interventional Oncology, National Institutes of Health
Co-authored papers 27
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 17
National Cancer Institute, National Institutes of Health
Co-authored papers 16
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Fukuoka University
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Boston Children's Hospital and Harvard Medical School
Co-authored papers 2
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 2
Frederick National Laboratory
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
Institute of Molecular and Cell Biology
Co-authored papers 1
Comprehensive Cancer Center
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Co-authored papers 1
Boston Children's Hospital
Co-authored papers 1
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1